>>> US Research Calls I

Research Calls I
  • Upgrades:
    • American Tower (AMT) upgraded to Outperform from Market Perform at Bernstein, tgt $207
    • Assured Guaranty (AGO) upgraded to Buy from Neutral at UBS, tgt $94
    • Credicorp (BAP) upgraded to Buy from Hold at HSBC, tgt $350
    • Jazz Pharmaceuticals (JAZZ) upgraded to Buy from Neutral at UBS, tgt $307
    • Progyny (PGNY) upgraded to Buy from Hold at Canaccord, tgt $30
    • StubHub Holdings (STUB) upgraded to Buy from Neutral at Guggenheim, tgt $12.50
  • Downgrades:
    • Biofrontera (BFRI) downgraded to Speculative Buy from Buy at Benchmark, tgt $3
    • CrowdStrike (CRWD) downgraded to Sell from Buy at DZ Bank, tgt $500
    • Fortinet (FTNT) downgraded to Hold from Buy at DZ Bank, tgt $125
    • James River Group Holdings (JRVR) downgraded to Neutral from Buy at UBS, tgt $4.75
    • The Hanover Insurance Group (THG) downgraded to Market Perform from Outperform at BMO Capital, tgt $203
  • Others:
    • Alnylam Pharmaceuticals (ALNY) initiated with a Buy at Citigroup, tgt $380
    • Ascendis Pharma (ASND) initiated with a Buy at Citigroup, tgt $355
    • BioMarin Pharmaceutical (BMRN) initiated with a Buy at Citigroup, tgt $75
    • BridgeBio Pharma (BBIO) initiated with a Neutral at Citigroup, tgt $82
    • CG Oncology (CGON) initiated with a Peer Perform at Wolfe Research
    • Corpay (CPAY) initiated with a Buy at Loop Capital, tgt $406
    • CytomX Therapeutics (CTMX) initiated with an Outperform at Wolfe Research, tgt $6
    • Cytokinetics (CYTK) initiated with a Buy at Citigroup, tgt $99
    • Interface (TILE) initiated with a Buy at Benchmark, tgt $36
    • Ionis Pharmaceuticals (IONS) initiated with a Buy at Citigroup, tgt $115
    • Lightspeed POS (LSPD) reinstated with an Underperform at BofA Securities, tgt $10
    • Mirum Pharmaceuticals (MIRM) initiated with an Outperform at Wolfe Research, tgt $145
    • NeOnc Technologies (NTHI) initiated with a Buy at Alliance Global, tgt $13
    • Oklo (OKLO) initiated with a Peer Perform at Wolfe Research
    • Pilgrim's Pride (PPC) reinstated with a Neutral at UBS, tgt $30
    • Rapport Therapeutics (RAPP) assumed with a Buy at Truist, tgt $56
    • Tyra Biosciences (TYRA) initiated with a Peer Perform at Wolfe Research
    • X-energy (XE) initiated with a Hold at Jefferies, tgt $28
    • X-energy (XE) initiated with a Buy at Guggenheim, tgt $57
    • X-energy (XE) initiated with a Buy at TD Cowen, tgt $35
    • X-energy (XE) initiated with a Buy at UBS, tgt $40
    • X-energy (XE) initiated with an Overweight at JPMorgan, tgt $38
    • X-energy (XE) initiated with an Overweight at Morgan Stanley, tgt $41
    • X-energy (XE) initiated with a Peer Perform at Wolfe Research
    • Zeta Global Holdings (ZETA) reinstated with a Buy at BofA Securities, tgt $24